Insight into the effects of chiral isomers quinidine and quinine on CYP2D6 inhibition

被引:23
作者
Ai, Chunzhi [1 ,2 ]
Li, Yan [3 ]
Wang, Yonghua [4 ]
Chen, Yadong [5 ]
Yang, Ling [1 ,2 ]
机构
[1] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian 116023, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China
[3] Dalian Univ Technol, Sch Chem Engn, Dalian 116012, Peoples R China
[4] Dalian Fisheries Univ, Sch Life Sci & CBiotechnol, Dalian 116023, Peoples R China
[5] China Pharmaceut Univ, Dept Basic Sci, Nanjing 210009, Peoples R China
关键词
Stereoisomer; CYP2D6; Inhibitor; CoMFA; CoMSIA; Docking; Molecular electrostatic potential; MOLECULAR-FIELD ANALYSIS; CYTOCHROME-P450; 2D6; BINDING; COMFA;
D O I
10.1016/j.bmcl.2008.12.016
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The distinct inhibitory effects against CYP2D6 enzyme of the stereoisomers quinidine and quinine were investigated in this work by employing various methods, including the comparative molecular field analysis (CoMFA), the comparative molecular similarity indices analysis (CoMSIA), the molecular electrostatic potential (MEP) analysis and the docking method. Several 3D-QSAR models with proper reliability were well established, with a CoMFA model with steric and electrostatic fields exhibiting 0.67, 0.99 and 0.88 of q(2), r(2) and r(2) pred, respectively, a CoMSIA model with steric, electrostatic and H-bond acceptor fields displaying 0.72, 0.97 and 0.84 of q(2), r(2) and r(pred)(2), respectively. These models and related docking results reveal that quinidine binds to CYP2D6 in an inverse orientation as compared with quinine. Moreover, quinidine blocks the entrance of the active pocket of CYP2D6 more closely than quinine does, which explains well why the inhibitory activity of quinidine is of 2 magnitudes larger than quinine. This investigation provides a better understanding of the stereoisometric effects on the bioactivities of the chiral isomers quinidine and quinine interacting with CYP2D6. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:803 / 806
页数:4
相关论文
共 15 条
[11]   A PREDICTIVE MODEL FOR SUBSTRATES OF CYTOCHROME P450-DEBRISOQUINE (2D6) [J].
KOYMANS, L ;
VERMEULEN, NPE ;
VANACKER, SABE ;
TEKOPPELE, JM ;
HEYKANTS, JJP ;
LAVRIJSEN, K ;
MEULDERMANS, W ;
DENKELDER, GMD .
CHEMICAL RESEARCH IN TOXICOLOGY, 1992, 5 (02) :211-219
[12]   Why is quinidine an inhibitor of cytochrome P450 2D6?: The role of key active-site residues in quinidine binding [J].
McLaughlin, LA ;
Paine, MJI ;
Kemp, CA ;
Maréchal, JD ;
Flanagan, JU ;
Ward, CJ ;
Sutcliffe, MJ ;
Roberts, GCK ;
Wolf, CR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (46) :38617-38624
[13]  
Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
[14]   Crystal structure of human cytochrome P450 2D6 [J].
Rowland, P ;
Blaney, FE ;
Smyth, MG ;
Jones, JJ ;
Leydon, VR ;
Oxbrow, AK ;
Lewis, CJ ;
Tennant, MG ;
Modi, S ;
Eggleston, DS ;
Chenery, RJ ;
Bridges, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) :7614-7622
[15]   DEVELOPMENT OF A PHARMACOPHORE FOR INHIBITION OF HUMAN LIVER CYTOCHROME-P-450 2D6 - MOLECULAR MODELING AND INHIBITION STUDIES [J].
STROBL, GR ;
VONKRUEDENER, S ;
STOCKIGT, J ;
GUENGERICH, FP ;
WOLFF, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (09) :1136-1145